title: Strategies involved in developing an effective vaccine for EBV-associated diseases.
authors.affiliation: The Queensland Institute of Medical Research, The Bancroft Centre, Herston, Australia.
authors.forename: D J
authors.initials: DJ
authors.lastname: Moss
authors.forename: C
authors.initials: C
authors.lastname: Schmidt
authors.forename: S
authors.initials: S
authors.lastname: Elliott
authors.forename: A
authors.initials: A
authors.lastname: Suhrbier
authors.forename: S
authors.initials: S
authors.lastname: Burrows
authors.forename: R
authors.initials: R
authors.lastname: Khanna
mesh_terms: D015967:Gene Expression Regulation, Viral; D006566:Herpesviridae Infections / Q000517:prevention & control*; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000502:physiology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000502:physiology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014412:Tumor Virus Infections / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology*; D014779:Virus Replication
chemical_list: D016169:Lymphocyte Function-Associated Antigen-1; D014765:Viral Vaccines; D018799:Intercellular Adhesion Molecule-1